COMMUNIQUÉS West-GlobeNewswire

-
Zealand Pharma conference call on February 27 at 2pm CET (8am ET) to present full year 2023 financial results
20/02/2024 -
Philogen provides update on pre-planned interim analysis of the Phase III FIBROSARC trial investigating Onfekafusp alfa (L19TNF) in patients with first-line advanced or metastatic Soft Tissue Sarcoma
20/02/2024 -
argenx Announces FDA Acceptance of Supplemental Biologics License Application with Priority Review for VYVGART Hytrulo in Chronic Inflammatory Demyelinating Polyneuropathy
20/02/2024 -
Opthea Appoints Arshad M. Khanani, MD, MA, FASRS, as Chief Medical Advisor
20/02/2024 -
Preparatory documents for the General Meeting as of of March 25, 2024
19/02/2024 -
Documents préparatoires à l'Assemblée Générale du 25 Mars 2024
19/02/2024 -
GUERBET : Nombre d'actions et de droits de vote composant le capital de la société au 31 janvier 2024
19/02/2024 -
Novo Nordisk A/S – Share repurchase programme
19/02/2024 -
Teladoc Health Provides Updated Start Time for Fourth Quarter 2023 Earnings Call on February 20, 2024
19/02/2024 -
Medigene to Present at Upcoming Conferences
19/02/2024 -
BioCryst Launches ORLADEYO® (berotralstat) in Italy
19/02/2024 -
CMR Surgical hires industry leader to drive operations across Asia Pacific, the Middle East and Africa
19/02/2024 -
Orion to investigate the possible outsourcing of its pharmaceutical production in Kuopio, Finland
19/02/2024 -
Transactions in connection with share buy-back program
19/02/2024 -
New collaboration between Boehringer Ingelheim and Sleip leverages AI-technology to help detect lameness in horses
19/02/2024 -
GN Store Nord A/S - Notice to convene the Annual General Meeting 2024
19/02/2024 -
Certa Therapeutics’ FT011 Granted US FDA Fast Track for the Treatment of Systemic Sclerosis
19/02/2024 -
CMR Surgical hires industry leader to drive operations across Asia Pacific, the Middle East and Africa
19/02/2024 -
BioPorto A/S to host investor meetings on 22 February 2024
19/02/2024
Pages